Aptose Biosciences Inc (APTO)

[Tartiaboy]

They are focused on AA for monotherapy in Flt3muti failures and or TP53/NPM1/Ras if warranted after expansion studies. That is the fastest path to approvals. That said I am extremely interested in the combination studies. I think that in view of how active TUSP is alone we will see very significant increase in CRs with TUSP + Ven.

APTO need some big clinical hits to ramp up its current valuation. Obviously that won't come from approvals. I think it could come from TUSP + Ven data.

I believe that few people understand where this is going. I am thinking way ahead of where APTO is, but I am also aware of the current situation and what needs to happen.